I conducted my Bachelor studies in Biotechnology (2007-2011) in the Autonomous University of Barcelona and continued them following a Master of Neuroscience (2011-2012) and a PhD in Biomedicine (2012-2017) at the University of Barcelona. I focused my PhD on studying the role of nuclear lamina alterations in Huntington’s disease (HD), specifically focusing on the effects of lamin associated domains (LADs) disruption in transcriptional dysregulation in HD mouse models, conducting transcriptomics (RNA-seq) and epigenomics (ChIP-seq and ATAC-seq) studies. Following this, I initiated my postdoctoral career in the Laboratory of Cognitive and Adaptive Neuroscience (LNCA) at the University of Strasbourg (2017-2022), studying epigenetic alterations in HD mouse models and their implications in cognitive dysfunction associated to the disease, applying previously acquired epigenetic approaches (ChIP-seq) and complementary 3D genome organization techniques (4C-seq). In 2022 I joined the Instituto de Neurociencias (CSIC-UMH) of Alicante thanks to the support, first, of a Juan de la Cierva Incorporación Postdoctoral Fellowship and, after, a La Caixa Postdoctoral Junior Group Leader Fellowship (2022) to study the role of lysine acetyl-transferase type 3 (KAT3) proteins in neuronal identity maintenance. I am currently stablishing my own research line focusing on the study of chromatin organization in the central nervous system thanks to the recent support of a Ramón y Cajal Fellowship.
I conducted my Bachelor studies in Biotechnology (2007-2011) in the Autonomous University of Barcelona and continued them following a Master of Neuroscience (2011-2012) and a PhD in Biomedicine (2012-2017) at the University of Barcelona. I focused my PhD on studying the role of nuclear lamina alterations in Huntington’s disease (HD), specifically focusing on the effects of lamin associated domains (LADs) disruption in transcriptional dysregulation in HD mouse models, conducting transcriptomics (RNA-seq) and epigenomics (ChIP-seq and ATAC-seq) studies. Following this, I initiated my postdoctoral career in the Laboratory of Cognitive and Adaptive Neuroscience (LNCA) at the University of Strasbourg (2017-2022), studying epigenetic alterations in HD mouse models and their implications in cognitive dysfunction associated to the disease, applying previously acquired epigenetic approaches (ChIP-seq) and complementary 3D genome organization techniques (4C-seq). In 2022 I joined the Instituto de Neurociencias (CSIC-UMH) of Alicante thanks to the support, first, of a Juan de la Cierva Incorporación Postdoctoral Fellowship and, after, a La Caixa Postdoctoral Junior Group Leader Fellowship (2022) to study the role of lysine acetyl-transferase type 3 (KAT3) proteins in neuronal identity maintenance. I am currently stablishing my own research line focusing on the study of chromatin organization in the central nervous system thanks to the recent support of a Ramón y Cajal Fellowship.